The present invention provides for a composition, kit and method for treatment of diseases, where the composition contains at least one catecholic butane, including NDGA compounds and derivatives, together with a pharmaceutically acceptable carrier that may include solubilizing agents or excipients, where the composition is suitable for injection into animals.
Astronaut Scholarship Foundation
Member, Asf Program Committee
American Association of Pharmaceutical Scientists (Aaps) Jan 2008 - Jan 2015
Aaps-Ncpdg: Various Positions Held
Quality Cmc Consulting Jan 2008 - Jan 2015
Owner
Biocryst Pharmaceuticals Mar 2011 - Dec 2012
Qa Manager
Inspire May 2009 - Feb 2011
Associate Director of Sterile Manufacturing
Education:
Duke University 1980 - 2003
Doctorates, Doctor of Philosophy, Philosophy, Chemistry
University of Central Florida 1994 - 1998
Bachelors, Bachelor of Science, Chemistry
Skills:
Gmp Regulatory Affairs Drug Development Pharmaceutical Industry Technology Transfer Clinical Trials Fda Pharmaceutics Biotechnology Glp Regulatory Submissions Life Sciences Cro Biopharmaceuticals Analytical Chemistry Validation Sop Hplc Chemistry Quality Assurance Drug Discovery Capa 21 Cfr Part 11 Gcp Oncology Clinical Development Regulatory Requirements R&D Gxp Formulation Chromatography Clinical Research V&V Ind Lifesciences Change Control Standard Operating Procedure Ctms